No One Else Does What We Do

Download Report

Transcript No One Else Does What We Do

NALOXONE: OPIOID
OVERDOSE RESCUE
MEDICATION
Not breathing
No oxygen to the brain
Brain damage





From 1999 to 2014, more than 165,000 people died from overdose
related to prescription opioids. - Center for Disease Control
In 2014, 18,893 people died of accidental overdose related to
prescription pain medications. -Center for Disease Control
In Oregon, prescription opioid overdose deaths increased by more
than 200% from 2000-2012 (48 to 164 deaths). –Oregon State
Medical Examiner. Drug Related Death Statistics
In 2015 heroin deaths totaled 12,990, a 23% increase since 2014. –
CDC via CNN
A total of 33,091 Americans died from opioid overdose last year.
Some of the deaths involved a combination of drugs –CDC via
CNN
Jack Fishman circa
unknown



Naloxone is a non- controlled
prescription medication.
It is non-addictive and
nontoxic
In 1961 it was first cited by
Jack Fishman and researched
by Harold Blumberg. Dr.
Fishman also extensively
studied steroids and the role
estrogen plays in breast cancer.



Naloxone is a pure opioid antagonist that does not produce
analgesic qualities
Naloxone has a an extremely high affinty for the mu opioid
receptor
It was preceded by nalorphine, however it caused analgesia and
in higher doses hallucinations.




Naloxone, also known as Narcan, is derived from
an opiate alkaloid called thebaine.
Naloxone reverses opioid overdose effects,
primarily respiratory depression.
Naloxone does not cause a release of dopamine.
Naloxone only will reverse an opioid/opiate
overdose. It has no effect on cocaine, alcohol,
methamphetamine, and or marijuana.
Applicator
2mg Naloxone Vial
Atomizer
Luer-Lock Naloxone Hydrochloride 2mg
https://www.youtube.com/watch
?v=oWopsRaeY6M

“The take-home naloxone program is
saving the lives of people who use
prescribed and illegal opioids. It is
proving that disability and deaths due to
opioid overdose are preventable with
education and the timely administration
of the medication.” -Dr. Jane Buxton
Head Harm Reduction Office, BC Centre
for Disease Control


“From 1996-June 2014 laypersons reported using
naloxone in 26, 463 reversals. In 2013 alone, nearly
40,000 laypersons with 93 organizations reported
8,032 overdose reversals.” -Huffington Post June
2015.
Closer to home and as of March 1, 2015, Outside In
and MCHD had trained more than 1,500
individuals who then reported reversing 701
overdoses. Heroin related deaths in Mult. Co.
dropped 29% in the first year after naloxone
became available to lay people there, compared to
the year before. – Public Health Issue Brief March
11, 2015.
100
90
84
80
70
60
86
83
29%
70
67
61
57
48
50
49
50
40
Any heroin
Any Rx
30
20
10
0
09-'10
11-'10
11-'12
12-'13
13-'14
OR Naloxone Law
Passed 2013
15
17
18
1.
2.
3.
4.
5.
6.
Person is not breathing or breathing is very
slow.
Person is turning pale, blue, or gray (esp. lips
and or nails).
There are snoring, gurgling, and or choking
sounds.
The persons body is limp.
The person is throwing up.
The person is unresponsive.




https://www.youtube.com/watch?v=FZpgjRB
by_M
Approved and certified by Oregon Addicitons
and Mental Health
Used to teach laypersons and persons using
opioids how to reverse an overdose
8 minutes in running length
Approved in November 2015, the device will cost roughly $76.00. It
will become available in 2016. One advantage of the new FDA
approved device is that it requires no assembly.

“I think it makes a lot of sense, for example, to
co-prescribe naloxone with chronic pain
medications so people will have it in their
home, in their medicine cabinet, and instruct
their family members how to use it so if
somebody is overdosing then they can
administer it to them while they wait for help
to arrive, just as you would for an epi-pen.”-Dr.
Alex Walley Massacusetts Opioid Overdose
Prevention

What providers can do

Assess need for naloxone education using the
following criteria:
1. 100mg or more morphine equivalents
2. Respiratory illness
3. Concurrent benzodiazepine or other sedative
prescription.
4. Request by patient or expressed concern by support
person(s)
5. History of substance abuse or non medical opioid use


SOAPP-R tool, DAST-10 or other screening
form completion is necessary for insurance to
cover medication.
CPT codes for Naloxone are:


-99408
-Education/screening time can be for 15-30 min



In conjunction with PDMP legislation, it was
passed in February 2016.
Allows pharmacists to prescribe and distribute
unit-of-use packages of Naloxone to
individuals who have completed a naloxone
training course.
Allows employees of social service agencies to
administer unit-of-use packages of Naloxone
on organization premises.
Current Partnering Pharmacies
Rite Aid
Walgreens
Fred Meyers
Safeway





Haven Wheelock at Outside In: [email protected]
Lindsay Jenkins at Multnomah County Health Department:
[email protected]
Teleflex provides atomization devices:
http://www.teleflex.com/en/usa/productAreas/ems/pro
ductGroups/atomizationDevices/products/
Save Lives provides patient training devices:
http://www.savelives.com/product/intranasal-naloxonetrainer-kit-8186.cfm
Patient teaching tool, Prescribe to Prevent:
https://www.youtube.com/watch?v=oWopsRaeY6M
Thank you for your time!